Retail investors often overlook hedge funds, as these vehicles are not aimed at them. Hedge fund managers are only allowed to market themselves to wealthy investors, with many demanding a minimum stake of at least £100,000.
Hedge funds are not like the investment funds available to the everyday investor. They are lightly regulated and can invest in a wide range of assets. The most common fund used to be the long/short equity fund.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Hedge funds: how to diversify your portfolio
Long/short funds still dominate the $4trn sector. Still, there are plenty of other strategies, such as algorithmic trading funds, debt-focused funds, macro funds (which trade assets such as bonds and commodities), commodity-focused funds, activist hedge funds and funds managed by short-sellers, who seek out the market’s disasters before they happen. But why would an investor want to own a hedge fund?
Put simply, hedge funds can provide diversification into various asset classes and provide exposure to different investment managers. Wealthy individuals may own stakes in several hedge funds alongside other investments to help them build exposure to trading strategies they may not understand or have the resources to trade.
Man Group (LSE: EMG) is the world’s largest publicly traded hedge-fund firm, and a good case study of how hedge funds operate. It specialises in trading foreign currencies using computer models and last year one of the best-performing investment strategies was a fund called Man AHL TargetRisk, which generated annual returns of 14.1% by trading assets such as credit-default swaps, futures contracts on stock indexes and government debt for France, Germany, the UK and the US.
Investors like this approach. The overall group’s assets under management surged by 17% last year to a record high of $167.5bn. Man Group takes annual management fees and performance fees if a certain performance hurdle is met on the funds. This is one of the easiest ways to profit from hedge funds without running the gauntlet of selecting one yourself. The stocks yield 5.7% and the company has been spending money to buy back stock.
Pershing Square Holdings (LSE: PSH) is an investment trust that follows the strategy of the Pershing Square hedge fund. It has earned one of the best returns of any investment trust thanks to its focused portfolio – another hallmark of hedge funds, as unlike open-ended retail funds they don’t need to conform to diversification rules. Over the past five years, Pershing Square’s hedge fund has returned 203.5%.
BH Macro (LSE: BHMG) is another investment-trust hedge fund. BH Macro tries to trade global financial markets, using instruments such as debt, foreign currencies, swaps and commodities to earn a positive annual return. Over the past decade the fund has returned 95.5%, providing profitable diversification to a portfolio. The trust’s sterling class is on a 12.2% discount to net asset value (NAV). If the discount stays wider than 8% over the year, shareholders are allowed a discontinuation vote in 2025. The board has bought back shares to try to close the discount.
Then there is Tetragon Financial Group (LSE: TFG). While technically not a hedge fund, the close-ended company invests like one. Its portfolio is a mix of private assets, bank loans, venture-capital equities and real estate. Since the firm listed in 2007, its NAV has risen by 426%, more than double the return of the MSCI All Country World index. The shares yield 4.6% and the fund has been buying back shares. The shares currently trade at a 69% discount to NAV.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
Top 10 areas with the biggest inheritance tax bills – is your town on the list?People in some of the wealthiest parts of London pay the most inheritance tax – but there are a few areas outside the capital where big bills are paid when a loved one dies
-
Inheritance tax reform ‘largely protects family farms’ – what are the alternatives?Independent analysis of the government’s inheritance tax reforms has found eight out of 10 farming estates will be able to pay their IHT bill without having to sell off parts of the farm
-
What we can learn from Britain’s "Dashing Dozen" stocksStocks that consistently outperform the market are clearly doing something right. What can we learn from the UK's top performers and which ones are still buys?
-
Europe’s forgotten equities offer value, growth and strong cash flowsOpinion Jonathon Regis, co-portfolio manager, Developed Markets UCITS Strategy, Lansdowne Partners, highlights forgotten equities he'd put his money in
-
The flaw in Terry Smith’s strategy at FundsmithOpinion Fundsmith has invested in some excellent companies, but it has struggled to decide when to sell, says Max King
-
How to invest in the travel industry's boom as tourists get back on the roadThe travel industry is in rude health despite uncertainty about the global economy, Trump’s policies and geopolitical concerns. Investors should buy in now
-
Earnings estimates are a rigged game – especially in the USThe number of US stocks beating earnings estimates tells us only that guidance has deliberately been set too low
-
Profit from the potential in funds focusing on private assetsOpinion Charlotte Cuthbertson and Tom Treanor of the Migo Opportunities Trust highlight three funds where they'd put their money
-
How to approach active ETFsActive ETFs have several advantages over other forms of open-ended investment vehicles, says David Prosser
-
How to cash in on investment trusts that are selling upManaged wind-downs and portfolio sales can be an attractive opportunity for patient investors
